Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
March 28, 2023
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020
Mark G Wise, James A Karlowsky, Elkin V Lemos-Luengas, et al.
FEMS Microbiology Ecology
|
April 27, 2011
Chicken intestine microbiota following the administration of lupulone, a hop-based antimicrobial
Glenn E Tillman, Gerhard J Haas, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program
Patricia A Bradford, Krystyna M Kazmierczak, Douglas J Biedenbach, et al.
International Journal of Antimicrobial Agents
|
November 6, 2018
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M Kazmierczak, Masakatsu Tsuji, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy
|
October 26, 2022
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of <i>Enterobacterales</i> from a 2018-2020 Global Surveillance Collection
James A Karlowsky, Mark G Wise, Meredith A Hackel, et al.
Jac-Antimicrobial Resistance
|
September 18, 2024
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22
Mark G Wise, C Andrew DeRyke, Irina Alekseeva, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
May 30, 2023
<i>In Vitro</i> Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014-2019
Mark G Wise, James A Karlowsky, Meredith A Hackel, et al.
Jac-Antimicrobial Resistance
|
January 1, 2024
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents-SMART 2018-21
James A Karlowsky, Mark G Wise, Wei-Ting Chen, et al.
Journal of the Pediatric Infectious Diseases Society
|
January 9, 2025
Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance
C Andrew DeRyke, Mark G Wise, Karri A Bauer, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 21, 2023
Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents - SMART 2018-2021
Mark G Wise, James A Karlowsky, Wei-Ting Chen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
March 28, 2023
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020
Mark G Wise, James A Karlowsky, Elkin V Lemos-Luengas, et al.
FEMS Microbiology Ecology
|
April 27, 2011
Chicken intestine microbiota following the administration of lupulone, a hop-based antimicrobial
Glenn E Tillman, Gerhard J Haas, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program
Patricia A Bradford, Krystyna M Kazmierczak, Douglas J Biedenbach, et al.
International Journal of Antimicrobial Agents
|
November 6, 2018
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M Kazmierczak, Masakatsu Tsuji, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy
|
October 26, 2022
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of <i>Enterobacterales</i> from a 2018-2020 Global Surveillance Collection
James A Karlowsky, Mark G Wise, Meredith A Hackel, et al.
Jac-Antimicrobial Resistance
|
September 18, 2024
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22
Mark G Wise, C Andrew DeRyke, Irina Alekseeva, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
May 30, 2023
<i>In Vitro</i> Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014-2019
Mark G Wise, James A Karlowsky, Meredith A Hackel, et al.
Jac-Antimicrobial Resistance
|
January 1, 2024
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents-SMART 2018-21
James A Karlowsky, Mark G Wise, Wei-Ting Chen, et al.
Journal of the Pediatric Infectious Diseases Society
|
January 9, 2025
Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance
C Andrew DeRyke, Mark G Wise, Karri A Bauer, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 21, 2023
Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents - SMART 2018-2021
Mark G Wise, James A Karlowsky, Wei-Ting Chen, et al.
Page
of 4